Eurosurveillance banner




Announcements
Follow Eurosurveillance on Twitter: @Eurosurveillanc


In this issue


Home Eurosurveillance Monthly Release  1999: Volume 4/ Issue 9 Article 3 Printer friendly version
Back to Table of Contents
en es fr it
Previous Next

Eurosurveillance, Volume 4, Issue 9, 01 September 1999
Articles
A case of tuberculosis on a long distance flight: the difficulties of the investigation

Citation style for this article: Vassiloyanakopoulos A, Spala G, Mavrou E, Hadjichristodoulou C. A case of tuberculosis on a long distance flight: the difficulties of the investigation . Euro Surveill. 1999;4(9):pii=83. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=83
A. Vassiloyanakopoulos, G. Spala, E. Mavrou, C. Hadjichristodoulou
National Center for Surveillance and Intervention (NCSI), Athens, Greece

Transmission of Mycobacterium tuberculosis from passenger to passenger aboard a long airplane flight was reported in 1996 (1). Other cases were previously published, in particular by the Centers for Disease Control which had then suggested criteria for epidemiological investigation in such cases (2). More recently, in 1998, the World Health Organization (WHO) has published guidelines on such investigations, emphasising duration of the flight (more than eight hours), the infectiousness of index patient, and the proximity of those exposed (3).

On 10 May 1998, the Swiss Office of Public Health (Division of Epidemiology and Public Health) informed the Greek National Centre for Surveillance and Intervention of an infectious case of tuberculosis who had travelled from Bangkok to Zurich via Athens on 15 April. He was a young Thai man, with productive cough and blood stained sputum. He had been admitted to hospital in the University Hospital of Basel, where abundant acid fast bacilli had been identified in spontaneously produced sputum and M. tuberculosis resistant to isoniazi had been cultured. Since the first part of his journey (Bangkok-Athens) had exceeded eight hours, we conducted an investigation to identify positive contacts.

A list of all 144 passengers from Bangkok to Athens and the crew was obtained from the airline company. The list of passengers included no addresses or telephone numbers so we tried to locate them from frequent flyer and tour operators’ records. The passengers and crew members were informed by telephone and letter about their potential exposure to tuberculosis and the possible risks and were advised to have a baseline tuberculin purified protein derivative (PPD) skin test, and to complete a questionnaire. PPD tests were to be repeated 12 weeks after exposure if the initial test was negative. If the baseline test was positive they were to be reviewed by experts for risk factors for tuberculosis.

Two investigators made about 600 telephone calls and sent 190 letters to notify passengers, tour operators, and hotels. Twenty passengers were contacted but only three had a baseline PPD test. Two had negative tests; chest radiography of the passenger with a positive PPD test showed no evidence of tuberculosis. None of the crew members responded to our notification, but we insisted that four members of the crew, who worked in the cabin area occupied by the index patient, were tested. In all four PPD was negative.

All contacts who had a negative baseline test were advised to have a repeat test for conversion. The crew members were retested with negative results and the passengers failed to comply.

The limited success of this case investigation reflected several constraints of such investigations. For several weeks we tried to contact people worldwide at an estimated cost of about US0.$4000 (3742 Euros) and 300 staff hours with very poor results among the passengers. One reason for the lack of success is that most airline companies have limited information about passengers. In addition, the compliance of the passengers was seriously affected by their diverse international origin (a fact for most long distance flights) and their distance from the investigators. Both factors also increase the cost of such investigations.

Our experience has made us skeptical about the cost-effectiveness of such investigations. Strategies for tuberculosis prevention and control vary between countries, making the interpretation of results difficult (4). Moreover, the risk of transmission of M. tuberculosis infection on aircraft appears to be no greater than in other confined spaces, and seems to be low (2,5).

Air carriers should be encouraged to keep full lists of passengers for some months after the flight. Furthermore, such case investigations should be restricted to highly infectious cases (for example, cases of laryngeal tuberculosis or cases of sputum positive tuberculosis who cough a lot during the flight) or cases infected with multidrug resistant strains of M. tuberculosis (6).

As our investigation ended, WHO published guidelines for the prevention and control of tuberculosis transmission during air travel (3). WHO’s guidelines also described difficulties encountered in such investigations. They are extremely labour intensive, taking time and resources from other important public health activities, as we found. WHO proposes that the best approach in many cases is to inform passengers and crew of their potential exposure to M. tuberculosis and to encourage them to seek medical assessment. WHO also proposes criteria to decide whether to inform passengers and crew; these criteria include the infectiousness of the person with active tuberculosis, duration of the flight, time interval between the flight and the notification of the case to the health authority, and proximity of passengers and crew to the index case.


References

1. Kenyon T, Valway S, Ihle W, Onorato I, Castro K. Transmission of multidrug-resistant mycobacterium tuberculosis during a long airplane flight. N Engl J Med 1996; 324; 15: 933-8.

2. CDC. Exposure of passengers and flight crew to M. Tuberculosis on commercial aircraft: 1992-1995. MMWR Morb Mortal Wkly Rep 1995; 44: 137-40.

3. World Health Organization. Tuberculosis and Air travel: Guidelines for Prevention and Control. Geneva: WHO, 1998.

4. CDC. National action plan to combat multi drug-resistant tuberculosis MMWR Morb Mortal Wkly Rep 1992; 41 (RR-11): 11-48.

5. Houk VN, Baker J, Sorensen K, Kent DC. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health 1968; 16: 26-35.

6. Braden CR, Valway SE, Oronato IM, Ussery XT, Grant SB, Dwyer D. Infectiousness of a university student with laryngeal and cavitary tuberculosis. Clin Infect Dis 1995; 21: 565-70.



Back to Table of Contents
en es fr it
Previous Next

Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2007-2013. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.